Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
When the COVID-19 pandemic swept into New Mexico in the spring of 2020, seriously ill patients from all over the state were brought to The University of New Mexico Hospital in Albuquerque, where many wound up in intensive care, breathing with the help of ventilators.
A study of COVID-19 patients at a New Mexico hospital finds that the virus hit American Indian patients particularly hard-;even though Native American patients had fewer other illnesses or conditions than non-native patients.
Researchers explored the evolutionary dynamics of swine influenza A virus (swIAV) populations in Asia's southern and eastern regions.
A new study of the strain of influenza A responsible for the 2009 H1N1 pandemic-;pdm09-;shows that the virus has passed from humans to swine about 370 times since 2009, and subsequent circulation in swine has resulted in the evolution of pdm09 variants that then jumped from swine to humans.
This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.
Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families.
Researchers present a modular framework for global sustainable networks of viral genomic surveillance.
Investigating Human metapneumovirus (HMPV) prevalence, genetic diversity, and evolution in respiratory tract infections (RTIs) for better understanding and management.
Rapid global expansion of highly pathogenic avian influenza A(H5N1) viruses in 2021, including reassortment with North American strains, highlights the need for proactive measures to combat their spread and mitigate the risk of a potential pandemic originating from these reassortants.
Researchers provided interim results on 2022-2023 influenza vaccine effectiveness (VE) estimates.
Nanoparticles have widely been used as advanced tools for the diagnosis, prevention, and treatment of infectious diseases.
Researchers reviewed existing data on pandemics and described the steps needed to prevent the emergence.
In a recent article published in the journal Immunity, researchers explained the concept of immunological imprinting and its underlying principles. They also discussed its potential role in the context of coronavirus disease 2019 (COVID-19) vaccines.
A recent study discussed influenza A virus infections in minks, emphasizing their contribution/role as an intermediate host.
In a recent study published in the Nature journal, researchers assessed the role of the airway-to-brain sensory pathways in influenza-induced illness.
Researchers discuss the results of an active surveillance analysis for the swine influenza virus.
Researchers evaluated the antimicrobial efficiency of two commercially available disinfectants containing quaternary ammonium compounds against influenza A virus (hemagglutinin 1 neuraminidase 1 (H1N1)), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and human coronavirus 229E.
The influenza season marks the beginning of a time of illness, sometimes serious or even fatal, in much of the world. For this reason, flu shots are recommended, especially for individuals with underlying diseases such as chronic hepatitis B (CHB) infection, since they are at higher risk for adverse outcomes.
Scientists have developed mathematical models that analyze the data obtained from an initial wave of the influenza pandemic to predict the dynamics of subsequent waves. Such predictions could be useful for pandemic preparedness.
Experts from the University of Barcelona, the Institute for Advanced Chemistry of Catalonia, the Institute of Microelectronics of Barcelona and the Aragon Nanoscience and Materials Institute of Aragon —a joint institute of the CSIC and the University of Zaragoza— have developed a new method to detect RNA viruses based on the triplex-forming probe technology.